3//SEC Filing
GV 2019 GP, L.L.C. 3
Accession 0000899243-21-024266
CIK 0001840574other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 7:28 PM ET
Size
9.6 KB
Accession
0000899243-21-024266
Insider Transaction Report
Form 3
GV 2019, L.P.
10% Owner
Holdings
- (indirect: By GV 2019 L.P.)
Series B Preferred Stock
→ Common Stock (443,265 underlying) - (indirect: By GV 2019 L.P.)
Series A-2 Preferred Stock
→ Common Stock (4,029,244 underlying)
GV 2019 GP, L.L.C.
10% Owner
Holdings
- (indirect: By GV 2019 L.P.)
Series B Preferred Stock
→ Common Stock (443,265 underlying) - (indirect: By GV 2019 L.P.)
Series A-2 Preferred Stock
→ Common Stock (4,029,244 underlying)
GV 2019 GP, L.P.
10% Owner
Holdings
- (indirect: By GV 2019 L.P.)
Series B Preferred Stock
→ Common Stock (443,265 underlying) - (indirect: By GV 2019 L.P.)
Series A-2 Preferred Stock
→ Common Stock (4,029,244 underlying)
Footnotes (3)
- [F1]The Series A-2 Preferred Stock is convertible into common stock on a 9.2595-for-1 basis into the number of shares of common stock shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
- [F2]The reported securities are held directly by GV 2019, L.P. GV 2019 GP, L.P. (the general partner of GV 2019, L.P.), GV 2019 GP, L.L.C. (the general partner of GV 2019 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2019 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2019 GP, L.P., GV 2019 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein.
- [F3]The Series B Preferred Stock is convertible into common stock on a 9.2595-for-1 basis into the number of shares of common stock shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
Documents
Issuer
Verve Therapeutics, Inc.
CIK 0001840574
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001845038
Filing Metadata
- Form type
- 3
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 7:28 PM ET
- Size
- 9.6 KB